Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy - Chiriboga, CA; Swoboda, KJ; Darras, BT; Iannaccone, ST; Montes, J; De Vivo, DC; Norris, DA; Bennett, CF; Bishop, KM (Neurology, 2016)